Anna Galicka
Overview
Explore the profile of Anna Galicka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krzyzewska A, Baranowska-Kuczko M, Galicka A, Kasacka I, Minczuk K, Kozlowska H
Pharmacol Rep
. 2024 Mar;
76(2):424-434.
PMID: 38519732
Background: Pulmonary hypertension (PH) can cause right ventricular (RV) failure and subsequent cardiohepatic syndrome referred to as congestive hepatopathy (CH). Passive blood stasis in the liver can affect inflammation, fibrosis,...
2.
Botor M, Augusciak-Duma A, Lesiak M, Sieron L, Dziedzic-Kowalska A, Witecka J, et al.
Pharmaceuticals (Basel)
. 2023 Oct;
16(10).
PMID: 37895885
() is a group of connective tissue disorders leading to abnormal bone formation, mainly due to mutations in genes encoding collagen type I (Col I). Osteogenesis is regulated by a...
3.
Galicka A, Szoka L, Radziejewska I, Marcinkiewicz C
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835499
Integrins play a fundamental role in the migration and invasiveness of glioblastoma (GBM) cells, making them suitable targets for innovative cancer therapy. The aim of this study was to evaluate...
4.
Radziejewska I, Supruniuk K, Jakimiuk K, Tomczyk M, Bielawska A, Galicka A
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37685842
Specific changes in mucin-type O-glycosylation are common for many cancers, including gastric ones. The most typical alterations include incomplete synthesis of glycan structures, enhanced expression of truncated O-glycans (Tn, T...
5.
Sutkowska-Skolimowska J, Branska-Januszewska J, Strawa J, Ostrowska H, Botor M, Gawron K, et al.
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142253
Osteogenesis imperfecta (OI) is a heterogeneous connective tissue disease mainly caused by structural mutations in type I collagen. Mutant collagen accumulates intracellularly, causing cellular stress that has recently been shown...
6.
Radziejewska I, Supruniuk K, Tomczyk M, Izdebska W, Borzym-Kluczyk M, Bielawska A, et al.
Int J Mol Sci
. 2022 Aug;
23(15).
PMID: 35955735
Abnormal glycosylation of cancer cells is considered a key factor of carcinogenesis related to growth, proliferation, migration and invasion of tumor cells. Many plant-based polyphenolic compounds reveal potential anti-cancer properties...
7.
Galicka A, Sutkowska-Skolimowska J
Int J Mol Sci
. 2021 Nov;
22(21).
PMID: 34768882
Benzophenone-3 (BP-3) is one of the most widely used chemical sunscreens. The results of many in vitro and in vivo tests confirm its high percutaneous penetration and systemic absorption, which...
8.
Botor M, Fus-Kujawa A, Uroczynska M, Stepien K, Galicka A, Gawron K, et al.
Biomolecules
. 2021 Oct;
11(10).
PMID: 34680126
Osteogenesis Imperfecta (OI) is a group of connective tissue disorders with a broad range of phenotypes characterized primarily by bone fragility. The prevalence of OI ranges from about 1:15,000 to...
9.
Sutkowska J, Hupert N, Gawron K, Strawa J, Tomczyk M, Forlino A, et al.
Pharmaceutics
. 2021 Jul;
13(7).
PMID: 34201872
Rosemary extract (RE) and lemon balm extract (LBE) attract particular attention of pharmacists due to their high therapeutic potential. Osteogenesis imperfecta (OI) type I is a heritable disease caused by...
10.
Kozlowska M, Brzoska M, Rogalska J, Galicka A
Nutrients
. 2020 Sep;
12(9).
PMID: 32927885
This study examined whether a polyphenol-rich extract from the berries of L. (AE; chokeberries) may protect from the impact of cadmium (Cd) on the metabolism of collagen in the liver....